Senior Scientist (In-vitro)
(Industry / CRO Experience is a Must)
Location – Nottingham
Sector – Drug Discovery
Salary – £30,000 - £35,000 (depending on interview performance & experience)
Full Time, Permanent Role
Do you have hands-on experience designing and running in vitro biochemical and cell-based assays within industry or a CRO? Do you have prior experience meeting experimental deadlines set by clients?
We have an exciting opportunity to join a drug discovery company in Nottingham, focused on receptor pharmacology. You will be supporting diverse client projects in cutting-edge drug discovery programs.
Applicants must have current UK work eligibility.
The Role
As a member of the receptor pharmacology team, you will be responsible for:
* Designing and performing in vitro biochemical and cell-based assays,
* Providing high-quality data to support drug discovery projects,
* Managing experiments and training junior team members,
* Working closely with clients and the team to solve complex research problems,
* Contributing to research publications and presenting findings at scientific meetings.
Current / Recent Experience Required:
The ideal candidate will have the following:
* At least 2 years of industry / CRO experience performing in vitro biochemical or cell-based assays (essential).
* Assay development experience (essential).
* Hands-on experience with in vitro molecular biology techniques – such as cell culture, PCR, western blotting, and flow cytometry (essential).
* Expertise in GPCR pharmacology (desirable).
* PhD or BSc / MSc in receptor pharmacology (desirable).
* Expertise in pharmacology laboratory techniques, including binding assays, SPR assays, radioligand binding, reporter gene assays (desirable).
Profile Required:
* Existing UK work eligibility (essential).
* Happy to commute / relocate to Nottingham (essential).
The Package
Our client, a leading collaborative drug discovery company, offers a competitive salary and benefits package. This full-time role provides the opportunity to join a growing organization at the forefront of receptor pharmacology